Literature DB >> 2416168

Enzyme production of propionibacteria from patients with acne vulgaris and healthy persons.

U Höffler, M Gehse, M Gloor, G Pulverer.   

Abstract

375 strains of propionibacteria isolated from pustules, comedones, and from normal skin of patients with acne vulgaris and from healthy persons have been examined for their enzymatic activity. In contrast to healthy individuals, protease and caseinase production of strains from acne patients was significantly lower. On the other hand, DNA'ase production of strains from acne lesions was increased, and lecithinase could be demonstrated in strains from acne patients only.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416168

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

1.  Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.

Authors:  B R Vowels; S Yang; J J Leyden
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

2.  Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.

Authors:  Teruaki Nakatsuji; Mandy C Kao; Jia-You Fang; Christos C Zouboulis; Liangfang Zhang; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

3.  Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

Authors:  Teruaki Nakatsuji; Yu-Tsueng Liu; Cheng-Po Huang; Christos C Zoubouis; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

4.  Activation of Deoxyribonuclease I by Nicotinamide as a New Strategy to Attenuate Tetracycline-Resistant Biofilms of Cutibacterium acnes.

Authors:  Yi-Hsien Shih; Donald Liu; Yen-Chou Chen; Ming-Hsuan Liao; Woan-Ruoh Lee; Shing-Chuan Shen
Journal:  Pharmaceutics       Date:  2021-05-31       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.